Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arachidonic Acid and Azelastine

Research Papers that Mention the Interaction

Pretreatment of alveolar macrophages with azelastine prevented the activation induced by PAF-acether and by the chemotactic peptide fMLP as estimated by the reduced liberation of arachidonic acid metabolites formed by the cyclooxygenase and the lipoxygenase pathways.
Similarly, a short pretreatment with azelastine (100 microM) prevented arachidonic acid-induced platelet aggregation.
Prostaglandins  •  1992  |  View Paper
The order of potency of the inhibitory effects on the arachidonic acid release were: homochlorcyclizine, clemastine, and azelastine (IC50 less than 20 microM) greater than oxatomide (IC50 less than 60 microM) and diphenylpyraline greater than triprolidine, meclizine, diphenhydramine (IC50 greater than 100 microM).
Journal of pharmacobio-dynamics  •  1991  |  View Paper
Results obtained in this study were as follows: (i) Formations of leukotriene B4 by neutrophils activated with a calcium ionophore (A23187) … of antiallergic drugs examined here, although the required concentrations were within a range of 20-200 microM. (ii) Releases of arachidonic acid from … azelastine and oxatomide … antiallergic drugs.
Japanese journal of pharmacology  •  1990  |  View Paper
The arachidonic acid-induced contraction of isolated guinea-pig tracheal rings was also inhibited both by azelastine (IC50=92.6 μmol/l) and NDGA (IC50=20.4 μmol/l).
Agents and Actions  •  2005  |  View Paper
Azelastine also reduced arachidonic acid-induced bronchoconstriction and LT-like material release from sensitised lungs, regardless of the presence of indomethacin.
European journal of pharmacology  •  1992  |  View Paper
The inhibition of the formation of the products of the lipoxygenase pathway of arachidonic acid metabolism by azelastine may contribute to its overall antiallergic, antiasthmatic, and pulmonary anti-inflammatory activities.
International archives of allergy and applied immunology  •  1990  |  View Paper
i) Azelastine , an antiallergic drug, inhibited arachidonic acid release as well as superoxide generation.
Journal of pharmacobio-dynamics  •  1989  |  View Paper
These experimental observations suggested that one of the important roles of the antiallergic agents including azelastine (known as a chemical mediator release inhibitor) and clemastine (known as a histamine H1 receptor antagonist) could be an inhibition of the first step of the arachidonic acid cascade.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica  •  1987  |  View Paper